1887

Abstract

, a Gram-negative pathogen, is the causative agent of melioidosis in humans. This bacterium can be isolated from the soil, stagnant and salt-water bodies, and human and animal clinical specimens. While extensive studies have contributed to our understanding of pathogenesis, little is known about how a harmless soil bacterium adapts when it shifts to a human host and exhibits its virulence. The bacterium’s large genome encodes an array of factors that support the pathogen’s ability to survive under stressful conditions, including the host’s internal milieu. In this study, we performed comparative transcriptome analysis of cultured in human plasma versus soil extract media to provide insights into gene expression that governs bacterial adaptation and infectivity in the host. A total of 455 genes were differentially regulated; genes upregulated in grown in human plasma are involved in energy metabolism and cellular processes, whilst the downregulated genes mostly include fatty acid and phospholipid metabolism, amino acid biosynthesis and regulatory function proteins. Further analysis identified a significant upregulation of biofilm-related genes in plasma, which was validated using the biofilm-forming assay and scanning electron microscopy. In addition, genes encoding known virulence factors such as capsular polysaccharide and flagella were also overexpressed, suggesting an overall enhancement of virulence potential when present in human plasma. This gene expression profile provides comprehensive information on ’s adaptation when shifted from the environment to the host. The induction of biofilm formation under host conditions may explain the difficulty in treating septic melioidosis.

Funding
This study was supported by the:
  • Kementerian Pendidikan Malaysia (Award FRGS/1/2016/SKK11/UKM/01/1)
    • Principle Award Recipient: SheilaNathan
  • Universiti Kebangsaan Malaysia (Award DIP-2021-020)
    • Principle Award Recipient: SheilaNathan
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000982
2023-04-05
2024-05-04
Loading full text...

Full text loading...

/deliver/fulltext/mgen/9/4/mgen000982.html?itemId=/content/journal/mgen/10.1099/mgen.0.000982&mimeType=html&fmt=ahah

References

  1. Limmathurotsakul D, Golding N, Dance DA, Messina JP, Pigott DM et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol 2016; 1:15008 [View Article]
    [Google Scholar]
  2. Stewart JD, Smith S, Binotto E, McBride WJ, Currie BJ et al. The epidemiology and clinical features of melioidosis in Far North Queensland: Implications for patient management. PLoS Negl Trop Dis 2017; 11:e0005411 [View Article]
    [Google Scholar]
  3. Musa HI, Hassan L, Shamsuddin ZH, Panchadcharam C, Zakaria Z et al. Physicochemical properties influencing presence of Burkholderia pseudomallei in soil from small ruminant farms in Peninsular Malaysia. PLoS One 2016; 11:e0162348 [View Article]
    [Google Scholar]
  4. Ong CEL, Wongsuvan G, Chew JSW, Kim TY, Teng LH et al. Presence of Burkholderia pseudomallei in soil and paddy rice water in a rice field in Northeast Thailand, but not in air and rainwater. Am J Trop Med Hyg 2017; 97:1702–1705 [View Article]
    [Google Scholar]
  5. Limmathurotsakul D, Kanoksil M, Wuthiekanun V, Kitphati R, deStavola B et al. Activities of daily living associated with acquisition of melioidosis in northeast Thailand: a matched case-control study. PLoS Negl Trop Dis 2013; 7:e2072 [View Article]
    [Google Scholar]
  6. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005; 18:383–416 [View Article] [PubMed]
    [Google Scholar]
  7. Meumann EM, Cheng AC, Ward L, Currie BJ. Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis 2012; 54:362–369 [View Article] [PubMed]
    [Google Scholar]
  8. Yoder-Himes DR, Chain PSG, Zhu Y, Wurtzel O, Rubin EM et al. Mapping the Burkholderia cenocepacia niche response via high-throughput sequencing. Proc Natl Acad Sci 2009; 106:3976–3981 [View Article]
    [Google Scholar]
  9. Yoder-Himes DR, Konstantinidis KT, Tiedje JM. Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One 2010; 5:e8724 [View Article]
    [Google Scholar]
  10. O’Grady EP, Sokol PA. Burkholderia cenocepacia differential gene expression during host-pathogen interactions and adaptation to the host environment. Front Cell Infect Microbiol 2011; 1:15 [View Article]
    [Google Scholar]
  11. Williams TC, Blackman ER, Morrison SS, Gibas CJ, Oliver JD. Transcriptome sequencing reveals the virulence and environmental genetic programs of Vibrio vulnificus exposed to host and estuarine conditions. PLoS One 2014; 9:e114376 [View Article]
    [Google Scholar]
  12. Hasan NA, Grim CJ, Haley BJ, Chun J, Alam M et al. Comparative genomics of clinical and environmental Vibrio mimicus. Proc Natl Acad Sci 2010; 107:21134–21139 [View Article]
    [Google Scholar]
  13. Ooi WF, Ong C, Nandi T, Kreisberg JF, Chua HH et al. The condition-dependent transcriptional landscape of Burkholderia pseudomallei. PLoS Genet 2013; 9:e1003795 [View Article]
    [Google Scholar]
  14. Chieng S, Carreto L, Nathan S. Burkholderia pseudomallei transcriptional adaptation in macrophages. BMC Genomics 2012; 13:328 [View Article]
    [Google Scholar]
  15. Price EP, Viberg LT, Kidd TJ, Bell SC, Currie BJ et al. Transcriptomic analysis of longitudinal Burkholderia pseudomallei infecting the cystic fibrosis lung. Microb Genom 2018; 4:e000194 [View Article]
    [Google Scholar]
  16. Lee SH, Chong CE, Lim BS, Chai SJ, Sam KK et al. Burkholderia pseudomallei animal and human isolates from Malaysia exhibit different phenotypic characteristics. Diagn Microbiol Infect Dis 2007; 58:263–270 [View Article]
    [Google Scholar]
  17. Ashdown LR, Koehler JM. Production of hemolysin and other extracellular enzymes by clinical isolates of Pseudomonas pseudomallei. J Clin Microbiol 1990; 28:2331–2334 [View Article]
    [Google Scholar]
  18. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009; 25:1105–1111 [View Article] [PubMed]
    [Google Scholar]
  19. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J et al. The sequence alignment/map format and SAMtools. Bioinformatics 2009; 25:2078–2079 [View Article]
    [Google Scholar]
  20. Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL et al. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol 2013; 31:46–53 [View Article] [PubMed]
    [Google Scholar]
  21. de Hoon MJL, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics 2004; 20:1453–1454 [View Article] [PubMed]
    [Google Scholar]
  22. Chen L, Yang J, Yu J, Yao Z, Sun L et al. VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res 2005; 33:325–328 [View Article]
    [Google Scholar]
  23. Sun GW, Chen Y, Liu Y, Tan G-Y, Ong C et al. Identification of a regulatory cascade controlling type III secretion system 3 gene expression in Burkholderia pseudomallei. Mol Microbiol 2010; 76:677–689 [View Article]
    [Google Scholar]
  24. Chantratita N, Tandhavanant S, Wikraiphat C, Trunck LA, Rholl DA et al. Proteomic analysis of colony morphology variants of Burkholderia pseudomallei defines a role for the arginine deiminase system in bacterial survival. J Proteomics 2012; 75:1031–1042 [View Article]
    [Google Scholar]
  25. Chuaygud T, Tungpradabkul S, Sirisinha S, Chua KL, Utaisincharoen P. A role of Burkholderia pseudomallei flagella as a virulent factor. Trans R Soc Trop Med Hyg 2008; 102:140–144 [View Article]
    [Google Scholar]
  26. Paksanont S, Sintiprungrat K, Yimthin T, Pumirat P, Peacock SJ et al. Effect of temperature on Burkholderia pseudomallei growth, proteomic changes, motility and resistance to stress environments. Sci Rep 2018; 8:9167 [View Article]
    [Google Scholar]
  27. Taweechaisupapong S, Kaewpa C, Arunyanart C, Kanla P, Homchampa P et al. Virulence of Burkholderia pseudomallei does not correlate with biofilm formation. Microb Pathog 2005; 39:77–85 [View Article]
    [Google Scholar]
  28. Chin CY, Hara Y, Ghazali AK, Yap SJ, Kong C et al. Global transcriptional analysis of Burkholderia pseudomallei high and low biofilm producers reveals insights into biofilm production and virulence. BMC Genomics 2015; 16:471 [View Article]
    [Google Scholar]
  29. Tunpiboonsak S, Mongkolrob R, Kitudomsub K, Thanwatanaying P, Kiettipirodom W et al. Role of a Burkholderia pseudomallei polyphosphate kinase in an oxidative stress response, motilities, and biofilm formation. J Microbiol 2010; 48:63–70 [View Article]
    [Google Scholar]
  30. Wiersinga WJ, Virk HS, Torres AG, Currie BJ, Peacock SJ et al. Melioidosis. Nat Rev Dis Primers 2018; 4:17107 [View Article] [PubMed]
    [Google Scholar]
  31. Woodman ME, Worth RG, Wooten RM. Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils. PLoS One 2012; 7:e52276 [View Article]
    [Google Scholar]
  32. Reckseidler-Zenteno SL, DeVinney R, Woods DE. The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition. Infect Immun 2005; 73:1106–1115 [View Article]
    [Google Scholar]
  33. O’Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol 2000; 54:49–79 [View Article] [PubMed]
    [Google Scholar]
  34. Hopf V, Göhler A, Eske-Pogodda K, Bast A, Steinmetz I et al. BPSS1504, a cluster 1 type VI secretion gene, is involved in intracellular survival and virulence of Burkholderia pseudomallei. Infect Immun 2014; 82:2006–2015 [View Article]
    [Google Scholar]
  35. Shalom G, Shaw JG, Thomas MS. In vivo expression technology identifies a type VI secretion system locus in Burkholderia pseudomallei that is induced upon invasion of macrophages. Microbiology 2007; 153:2689–2699 [View Article]
    [Google Scholar]
  36. França A, Cerca N. Plasma is the main regulator of Staphylococcus epidermidis biofilms virulence genes transcription in human blood. Pathog Dis 2016; 74:125 [View Article]
    [Google Scholar]
  37. França A, Carvalhais V, Maira-Litrán T, Vilanova M, Cerca N et al. Alterations in the Staphylococcus epidermidis biofilm transcriptome following interaction with whole human blood. Pathog Dis 2014; 70:444–448 [View Article]
    [Google Scholar]
  38. França A, Pier GB, Vilanova M, Cerca N. Transcriptomic analysis of Staphylococcus epidermidis biofilm-released cells upon interaction with human blood circulating immune cells and soluble factors. Front Microbiol 2016; 7:1143 [View Article]
    [Google Scholar]
  39. Thänert R, Goldmann O, Beineke A, Medina E. Host-inherent variability influences the transcriptional response of Staphylococcus aureus during in vivo infection. Nat Commun 2017; 8:14268 [View Article]
    [Google Scholar]
  40. Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M et al. Bacterial biofilm and associated infections. J Chin Med Assoc 2018; 81:7–11 [View Article] [PubMed]
    [Google Scholar]
  41. Warawa J, Woods DE. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model. FEMS Microbiol Lett 2005; 242:101–108 [View Article]
    [Google Scholar]
  42. Gutierrez MG, Pfeffer TL, Warawa JM. Type 3 secretion system cluster 3 is a critical virulence determinant for lung-specific melioidosis. PLoS Negl Trop Dis 2015; 9:e3441 [View Article]
    [Google Scholar]
  43. Neamnak J, Tabunhan S, Wongwajana S, Wongratanacheewin S, Chamgramol Y et al. Comparison of stress adaptation and survival rate between Burkholderia pseudomallei with mutant and wild type bfmR. Southeast Asian J Trop Med Public Health 2014; 45:346–351
    [Google Scholar]
  44. Tuanyok A, Kim HS, Nierman WC, Yu Y, Dunbar J et al. Genome-wide expression analysis of iron regulation in Burkholderia pseudomallei and Burkholderia mallei using DNA microarrays. FEMS Microbiol Lett 2005; 252:327–335 [View Article]
    [Google Scholar]
  45. Tabunhan S, Wongratanacheewin S, Wongwajana S, Welbat TU, Faksri K et al. Characterization of a novel two-component system response regulator involved in biofilm formation and a low-iron response of Burkholderia pseudomallei. Southeast Asian J Trop Med Public Health 2014; 45:1065–1079
    [Google Scholar]
  46. Hunt TA, Kooi C, Sokol PA, Valvano MA. Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun 2004; 72:4010–4022 [View Article]
    [Google Scholar]
  47. Law RJ, Hamlin JNR, Sivro A, McCorrister SJ, Cardama GA et al. A functional phenylacetic acid catabolic pathway is required for full pathogenicity of Burkholderia cenocepacia in the Caenorhabditis elegans host model. J Bacteriol 2008; 190:7209–7218 [View Article]
    [Google Scholar]
  48. Pribytkova T, Lightly TJ, Kumar B, Bernier SP, Sorensen JL et al. The attenuated virulence of a Burkholderia cenocepacia paaABCDE mutant is due to inhibition of quorum sensing by release of phenylacetic acid. Mol Microbiol 2014; 94:522–536 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.000982
Loading
/content/journal/mgen/10.1099/mgen.0.000982
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error